Trials / Completed
CompletedNCT02373371
Actinic Keratoses Treatment With Metvix® in Combination With Light
Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- University Hospital, Limoges · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy in subjects with mild actinic keratoses (intra-individual comparison)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metvix® | |
| PROCEDURE | Photodynamic Therapy Blue light | Photodynamic therapy (PDT) is a medical treatment that utilizes a photosensitizing molecule (Metvix) and a blue light source to activate the applied drug |
| PROCEDURE | Photodynamic Therapy Daylight | Photodynamic therapy (PDT) is a medical treatment that utilizes a photosensitizing molecule (Metvix) and a the day light to activate the applied drug |
Timeline
- Start date
- 2015-03-25
- Primary completion
- 2016-11-22
- Completion
- 2018-06-01
- First posted
- 2015-02-27
- Last updated
- 2025-07-29
- Results posted
- 2019-04-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02373371. Inclusion in this directory is not an endorsement.